All stock lists
Faeth Therapeutics, Inc. (NASDAQ:FTH)
US · Delayed Price · Currency is USD
Also listed: SNSEHealthcare · Biotechnology
19.65+0.42 (+2.18%)
Market cap
$507M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 4, 2021
Website
Insider Score
––Not scored
FTH Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
FTH Stock Insider Trading Activity
FTH stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Parikh Anand Kiran CEO | Gift | 100,000 | — | — | 12.2% | 717,699 | Oct 30, 2026 | — | Form 4 |
| Parikh Anand Kiran CEO | Gift | 100,000 | — | — | New | 100,000 | Oct 30, 2026 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.